Literature DB >> 15388885

Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes.

C L Frankenfeld1, C Atkinson, W K Thomas, E L Goode, A Gonzalez, T Jokela, K Wähälä, S M Schwartz, S S Li, J W Lampe.   

Abstract

Particular intestinal bacteria metabolize the soy isoflavone daidzein to equol and O-desmethylangolensin (O-DMA), metabolites that can be identified in urine. Individuals that harbor bacteria capable of producing equol or O-DMA are known as equol producers (approximately 30%-50% of the population) and O-DMA producers (approximately 80%-90% of the population), respectively. The equol-producer phenotype has been associated with sex hormone-related outcomes in several studies. However, the bacteria responsible for these phenotypes have not yet been identified and factors that influence the manifestation of these phenotypes are not well understood. To evaluate familial clustering of and nongenetic factors associated with these phenotypes, 410 individuals from 112 families participated in phenotyping (3-day soy challenge and Day 4 spot urine collection). In segregation analyses of the equol-producer phenotype, the Mendelian dominant model provided the most parsimonious fit to the data, suggesting that the pattern of inheritance of the equol-producer phenotype is consistent with an autosomal dominant trait. This phenotype was positively associated with education (p trend = 0.01), but not with sex, smoking, or several dietary factors. Results of the segregation analyses of the O-DMA-producer phenotype were inconclusive; no other models provided a more parsimonious fit to the data than the general model. This phenotype was inversely associated with age in a nonlinear model (p = 0.01), positively associated with age- and sex-adjusted height (odds ratio [OR] 10-cm increase = 0.38, 95% confidence interval [CI] = 0.15, 0.95) and body mass index (kg/m(2)) (OR = 0.91, 95% CI = 0.85, 0.96), but not with sex, education, smoking, or several dietary factors. These results suggest the equol-producer phenotype may be under some degree of genetic control and that there are likely other environmental factors not evaluated in the present analysis that contribute to both of these phenotypes. These results provide a foundation for further work to refine our understanding of heritable and environmental determinants of daidzein-metabolizing phenotypes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15388885     DOI: 10.1177/153537020422900906

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  28 in total

Review 1.  Equol: history, chemistry, and formation.

Authors:  Kenneth D R Setchell; Carlo Clerici
Journal:  J Nutr       Date:  2010-06-02       Impact factor: 4.798

2.  Regulation of the neuroendocrine axis in male rats by soy-based diets is independent of age and due specifically to isoflavone action†.

Authors:  Bamidele O Jeminiwa; Rachel M Knight; Tim D Braden; Crisanta Cruz-Espindola; Dawn M Boothe; Benson T Akingbemi
Journal:  Biol Reprod       Date:  2020-10-05       Impact factor: 4.285

3.  Isoflavone pharmacokinetics and metabolism after consumption of a standardized soy and soy-almond bread in men with asymptomatic prostate cancer.

Authors:  Jennifer H Ahn-Jarvis; Steven K Clinton; Elizabeth M Grainger; Kenneth M Riedl; Steven J Schwartz; Mei-Ling T Lee; Raul Cruz-Cano; Gregory S Young; Gregory B Lesinski; Yael Vodovotz
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-14

Review 4.  Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.

Authors:  C T Peterson; V Sharma; L Elmén; S N Peterson
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

5.  Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.

Authors:  C L Frankenfeld; C Atkinson; K Wähälä; J W Lampe
Journal:  Eur J Clin Nutr       Date:  2014-02-26       Impact factor: 4.016

6.  Equol production changes over time in pre-menopausal women.

Authors:  Adrian A Franke; Jennifer F Lai; Ian Pagano; Yukiko Morimoto; Gertraud Maskarinec
Journal:  Br J Nutr       Date:  2011-09-16       Impact factor: 3.718

7.  A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women.

Authors:  Carey E Gleason; Cynthia M Carlsson; Jodi H Barnet; Sarah A Meade; Kenneth D R Setchell; Craig S Atwood; Sterling C Johnson; Michele L Ries; Sanjay Asthana
Journal:  Age Ageing       Date:  2008-12-02       Impact factor: 10.668

8.  Is equol the key to the efficacy of soy foods?

Authors:  Johanna W Lampe
Journal:  Am J Clin Nutr       Date:  2009-04-08       Impact factor: 7.045

9.  Comparative activities of daidzein metabolites, equol and O-desmethylangolensin, on bone mineral density and lipid metabolism in ovariectomized mice and in osteoclast cell cultures.

Authors:  Takuya Ohtomo; Mariko Uehara; José Luis Peñalvo; Herman Adlercreutz; Shin-ichi Katsumata; Kazuharu Suzuki; Ken Takeda; Ritsuko Masuyama; Yoshiko Ishimi
Journal:  Eur J Nutr       Date:  2008-07-11       Impact factor: 5.614

10.  Validity and reproducibility of a self-administered semi-quantitative food-frequency questionnaire for estimating usual daily fat, fibre, alcohol, caffeine and theobromine intakes among Belgian post-menopausal women.

Authors:  Selin Bolca; Inge Huybrechts; Mia Verschraegen; Stefaan De Henauw; Tom Van de Wiele
Journal:  Int J Environ Res Public Health       Date:  2009-01-06       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.